Format

Send to

Choose Destination
Leuk Lymphoma. 2018 Sep;59(9):2015-2017. doi: 10.1080/10428194.2018.1430797. Epub 2018 Feb 7.

Lenalidomide in non-deletion 5q lower-risk myelodysplastic syndromes: a glass quarter full or three quarters empty?

Author information

1
a Department of Internal Medicine School of Medicine , Yale University , New Haven , USA.
2
b Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University , New Haven , USA.
PMID:
29411698
DOI:
10.1080/10428194.2018.1430797
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center